1. BLACKWELL, G.J., CARNUCCIO, R., DI ROSA, M., FLOWER, R.J., IVANYI, J., LANGHAM, C.S.J., PARENTE, L., PERSICO, P. & WOOD, J. (1983). Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides. Adv. Prostaglandin, Thromboxane, Leukotriene Res., 11, 65–71.
2. BLACKWELL, G.J., CARNUCCIO, R., DI ROSA, M., FLOWER, R.J., LANGHAM, C.S.J., PARENTE, L., PERSICO, P., RUSSELL-SMITH, N.C. & STONE, D. (1982). Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br. J. Pharmac., 76, 185–194.
3. BLACKWELL, G.J., CARNUCCIO, R., DI ROSA, M., FLOWER, R.J., PARENTE, L. & PERSICO, P. (1980). Macrocortin: a polypeptide causing the antiphospholipase effect of glucocorticoids. Nature, 287, 147–149.
4. CLOIX, J.F., COLARD, O., ROTHHUT, B. & RUSSO-MARIE, F. (1983). Characterization and partial purification of ‘renocortins’: two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids. Br. J. Pharmac, 79, 313–321.
5. FLEER, E.A.M., VERHEIJ, H.M. & DE HAAS, G.H. (1981). Modification of carboxylate groups in bovine pancreatic phospholipase A2. Identification of aspartate-49 as Ca2+-binding ligand. Eur. J. Biochem., 113, 283–288.